BDA advises Neoss on its sale to CareCapital Advisors

BDA Partners is pleased to announce that its client, Neoss Limited (“Neoss”), has been acquired by CareCapital Advisors Limited (“CareCapital”), an equity investor focused on the dental and oral care industry.

CareCapital is one of the largest dental investors in the world, having invested more than US$1bn in the sector, and provides a patient and collaborative environment for dental entrepreneurs and talented executives to realize their customer-centric visions. In conjunction with the transaction, Dr Robert Gottlander has been appointed as President and Chief Executive Officer of Neoss.

Neoss, headquartered in the United Kingdom, is a leading global dental implant company committed to designing intelligently simple solutions that provide reliable and cost-effective patient care with excellent long-term results. The company offers a full range of product solutions from implants, abutments and accessories for a variety of treatment protocols. The Neoss brand is synonymous with innovation and quality, along with continuous product improvement.

BDA was the exclusive financial advisor to Neoss and the investors backing Neoss, notably MMC Ventures and Delta Partners, on the transaction.   

Dai Feng, Co-Founder and Managing Director of CareCapital, stated, “We are excited to welcome Neoss and Robert into our family. Both are dental trailblazers that, coupled, will elevate the Neoss customer experience and advance the Neoss mission. The company’s well–established brand, history of innovation, clinical validation and solid market position fit well with Robert’s customer-centric principles and passion for innovation.”

Michael J. Dormer, Chairman and CEO of Neoss, stated, “Reflecting on a wonderful journey over the past 20 years in which Neoss has built a formidable position in the dental marketplace, it is with great pride that our management team, staff and partners will be central to the next stage of progression under new ownership.”

Andrew Huntley, Senior Managing Director and Head of Health, BDA, said, “BDA has built significant transactional experience across the dental ecosystem, and we’re delighted to have used that experience to support Neoss in moving on to its next stage of growth with a strong global partner rooted in Asia. This transaction fits the trend of increasing investment in innovative dental implant technology which remains a fast growing sector.”

Jonathan Aiken, Managing Director, BDA, said, “We are proud to have advised Neoss on its successful sale to CareCapital. We are confident CareCapital is an ideal partner for Neoss as it continues its international expansion into new markets. This transaction reflects strong, secular cross-border investment trends in dental implant solutions and medical devices.”